Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sperm microtubule inner protein 4 (SPMIP4) is a protein localized to the centrosome and sperm flagella, where it forms part of the microtubule inner proteins (MIPs) embedded in dynein-decorated doublet microtubules (DMTs)[2][4][6][8]. SPMIP4 acts to reinforce and stabilize the microtubule structure, supporting the mechanical integrity necessary for sperm flagellar beating and motility[1][2][8]. It is critical for maintaining the axonemal architecture required for effective sperm movement but is not known to be involved in signal transduction, metabolic regulation, or any pathway currently exploited by therapeutic drugs[2][4][8][11]. There is no evidence directly linking SPMIP4 to disease, nor is it a target for pharmacological intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sperm microtubule inner protein 4 (SPMIP4).